Responsible for investment activities for Research Corporation Technologies (RCT), a $300+ million investment firm focused in the life sciences. Currently, Paul is focused on medical device opportunities.
We鈥檝e updated our privacy policy so that we are compliant with changing global privacy regulations and to provide you with insight into the limited ways in which we use your data.
You can read the details below. By accepting, you agree to the updated privacy policy.
